Supplement to: Single-dose oritavancin in the treatment of acute bacterial skin infections.

  • Corey, Ralph G. M.D
  • Kabler, Heidi M.D.
  • Mehra, Purvi M.D.
  • Gupta, Sandeep M.D.
  • Overcash, Scott J. M.D
  • Porwal, Ashwin M.D.
  • Giordano, Philip M.D.
  • Lucasti, Christopher M.D.
  • Perez, Antonio M.D.
  • Good, Samantha Ph.D.
  • Jiang, Hai Ph.D.
  • Moeck, Greg Ph.D.
  • O'Riordan, William M.D.

  • Single-dose Oritavancin compared to 7-10 days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections; the SOLO I Study.

This appendix has been provided by the authors to give readers additional information about the study.

New England Journal of Medicine 370(23), June 5, 2014.
Copyright © 2014 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF